Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Discover world index performance examples to understand how major benchmarks behave across regions and periods. This primer helps investors compare scales and draw quick insights.
21,743 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
U.S. authorities charged Supermicro co-founder Yih-Shyan Liaw and two associates with orchestrating a multi-billion-d...
A Reuters briefing this week reignited the debate over Banksy’s anonymity and its effect on art values, prompting a r...
The Federal Reserve just paused rates, signaling a hold as markets weigh the impact on Social Security income and ret...
As crypto markets shift, only these crypto tokens sit closest to their all-time highs, signaling selective strength e...
AppLovin exposes investors to a volatile mix of ad spend cycles and AI disruption fears. This guide breaks down the d...
Colombia unveils a bold plan to turn the Caribbean coast into a bitcoin mining hub powered by renewable energy, tying...
Retail investors chasing nat gas bets via front-month futures confront a hidden drag. The roll yield trap that gnaws ...
A new wave of small modular reactors could reshape the US power mix. This article explains why NuScale Power is catch...
Qualcomm is betting big on non-phone AI devices, teaming with top AI firms to power wearables that act as autonomous ...
Solana co-founder just confirmed that the Alpenglow upgrade is on track to ship next quarter, a milestone that could ...
TONX reported healthy momentum in Q1 2026, but the real story lies in its growth engine. This article breaks down th...